A decision by the US Supreme Court not to hear an appeal by Boston Scientific in a drawn-out cardiac device patent infringement case may have international implications for medical device manufacturers1.
The Supreme Court’s decision, denying a petition for writ of certiorari, leaves intact a 2009 ruling of the Court of Appeals for the Federal Circuit that dealt with the issue of “extra-territorial” applicability of US patents2...
Please login to read the full article.
